Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Boehringer Ingelheim
AstraZeneca
McKinsey
Harvard Business School

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LABETALOL HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Labetalol Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000291 Effects of Labetalol on Human Cocaine Use - 8 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 1997-10-01 The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000291 Effects of Labetalol on Human Cocaine Use - 8 Completed National Institute on Drug Abuse (NIDA) Phase 2 1997-10-01 The purpose of this study is to determine the effect of labetalol treatment on the subjective and physiological effects of cocaine.
NCT00000297 Effects of Labetalol on Nicotine Administration in Humans - 14 Completed University of Minnesota - Clinical and Translational Science Institute Phase 2 1998-10-01 The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
NCT00000297 Effects of Labetalol on Nicotine Administration in Humans - 14 Completed National Institute on Drug Abuse (NIDA) Phase 2 1998-10-01 The purpose of this study is to investigate the effects of labetalol in response to intravenous nicotine
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Labetalol Hydrochloride

Condition Name

Condition Name for Labetalol Hydrochloride
Intervention Trials
Hypertension 5
Preeclampsia 4
Hypertension in Pregnancy 3
Pre-Eclampsia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Labetalol Hydrochloride
Intervention Trials
Pre-Eclampsia 14
Hypertension 14
Hypertension, Pregnancy-Induced 8
Eclampsia 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Labetalol Hydrochloride

Trials by Country

Trials by Country for Labetalol Hydrochloride
Location Trials
United States 28
Canada 6
Egypt 5
Pakistan 2
Saudi Arabia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Labetalol Hydrochloride
Location Trials
New York 7
California 4
Tennessee 3
Texas 2
Ohio 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Labetalol Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Labetalol Hydrochloride
Clinical Trial Phase Trials
Phase 4 16
Phase 3 5
Phase 2/Phase 3 3
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Labetalol Hydrochloride
Clinical Trial Phase Trials
Recruiting 15
Completed 15
Not yet recruiting 7
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Labetalol Hydrochloride

Sponsor Name

Sponsor Name for Labetalol Hydrochloride
Sponsor Trials
University of Alberta 3
Cedars-Sinai Medical Center 3
Mansoura University 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Labetalol Hydrochloride
Sponsor Trials
Other 53
NIH 3
Industry 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Boehringer Ingelheim
McKesson
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.